KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Palvella Therapeutics (PVLA) Other Gross PP&E Adjustments (2016 - 2026)

Palvella Therapeutics has reported Other Gross PP&E Adjustments over the past 10 years, most recently at $22.9 million for Q4 2022.

  • Quarterly Other Gross PP&E Adjustments changed 0.02% to $22.9 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $22.9 million through Dec 2022, changed 0.02% year-over-year, with the annual reading at $22.9 million for FY2022, 0.02% changed from the prior year.
  • Other Gross PP&E Adjustments was $22.9 million for Q4 2022 at Palvella Therapeutics, up from $20.8 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $23.9 million in Q4 2020 and troughed at $7.7 million in Q1 2018.
  • The 5-year median for Other Gross PP&E Adjustments is $21.1 million (2020), against an average of $17.8 million.
  • Year-over-year, Other Gross PP&E Adjustments surged 155.14% in 2020 and then decreased 9.21% in 2022.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $8.4 million in 2018, then soared by 133.31% to $19.6 million in 2019, then grew by 21.87% to $23.9 million in 2020, then dropped by 4.17% to $22.9 million in 2021, then increased by 0.02% to $22.9 million in 2022.
  • Per Business Quant, the three most recent readings for PVLA's Other Gross PP&E Adjustments are $22.9 million (Q4 2022), $20.8 million (Q3 2022), and $22.1 million (Q2 2022).